Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - DECHRA PHARMACEUTICALS PLC Amend

2 Nov 2023 08:49

RNS Number : 1860S
Barclays PLC
02 November 2023

FORM 8.3 Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

DECHRA PHARMACEUTICALS PLC

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e)

Date position held/dealing undertaken:

24 Oct 2023

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing(if any)

Class of relevant security:

1p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

7,686,661

6.75%

2,001,764

1.76%

(2) Cash-settled derivatives:

1,340,927

1.18%

7,585,059

6.66%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

9,027,588

7.93%

9,586,823

8.42%

(b)

Rights to subscribe for new securities (including directors and other executive options)

Class of relevant security in relation to which subscription right exists

Details, including nature of the rights concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

1p ordinary

Purchase

107,949

37.8000 GBP

1p ordinary

Purchase

49,406

37.6130 GBP

1p ordinary

Purchase

47,153

37.7457 GBP

1p ordinary

Purchase

26,221

37.7788 GBP

1p ordinary

Purchase

25,085

37.6000 GBP

1p ordinary

Purchase

23,891

37.7475 GBP

1p ordinary

Purchase

13,817

37.7600 GBP

1p ordinary

Purchase

11,034

37.8189 GBP

1p ordinary

Purchase

10,575

37.7843 GBP

1p ordinary

Purchase

8,102

37.7076 GBP

1p ordinary

Purchase

7,557

37.7665 GBP

1p ordinary

Purchase

4,391

37.7865 GBP

1p ordinary

Purchase

4,302

37.7697 GBP

1p ordinary

Purchase

4,068

37.6923 GBP

1p ordinary

Purchase

3,297

37.7091 GBP

1p ordinary

Purchase

3,062

37.6891 GBP

1p ordinary

Purchase

3,000

37.7651 GBP

1p ordinary

Purchase

2,870

37.7100 GBP

1p ordinary

Purchase

2,258

37.7790 GBP

1p ordinary

Purchase

2,119

37.7650 GBP

1p ordinary

Purchase

888

37.6005 GBP

1p ordinary

Purchase

694

37.8157 GBP

1p ordinary

Purchase

560

37.7255 GBP

1p ordinary

Purchase

400

37.7500 GBP

1p ordinary

Purchase

376

37.7200 GBP

1p ordinary

Purchase

368

37.7400 GBP

1p ordinary

Purchase

341

37.7000 GBP

1p ordinary

Purchase

305

37.8200 GBP

1p ordinary

Purchase

257

37.8600 GBP

1p ordinary

Purchase

186

37.7531 GBP

1p ordinary

Purchase

133

37.6438 GBP

1p ordinary

Purchase

116

37.6200 GBP

1p ordinary

Sale

73,279

37.7597 GBP

1p ordinary

Sale

52,877

37.6043 GBP

1p ordinary

Sale

23,477

37.5647 GBP

1p ordinary

Sale

6,433

37.8000 GBP

1p ordinary

Sale

4,364

37.5851 GBP

1p ordinary

Sale

3,839

37.4757 GBP

1p ordinary

Sale

3,301

37.5737 GBP

1p ordinary

Sale

1,838

37.6000 GBP

1p ordinary

Sale

1,739

37.5759 GBP

1p ordinary

Sale

1,668

37.7853 GBP

1p ordinary

Sale

1,479

37.3727 GBP

1p ordinary

Sale

1,269

37.4637 GBP

1p ordinary

Sale

1,154

37.6387 GBP

1p ordinary

Sale

1,019

37.7436 GBP

1p ordinary

Sale

631

37.7600 GBP

1p ordinary

Sale

498

37.7868 GBP

1p ordinary

Sale

376

37.7200 GBP

1p ordinary

Sale

368

37.7400 GBP

1p ordinary

Sale

331

37.8100 GBP

1p ordinary

Sale

324

37.8061 GBP

1p ordinary

Sale

286

37.7625 GBP

1p ordinary

Sale

257

37.8600 GBP

1p ordinary

Sale

255

37.6058 GBP

1p ordinary

Sale

116

37.6200 GBP

(b)

Cash-settled derivative transactions

Class of relevant security

Product description

Nature of dealing

Number of reference securities

Price per unit

1p ordinary

SWAP

Long

324

37.8061 GBP

1p ordinary

CFD

Long

1,019

37.7436 GBP

1p ordinary

SWAP

Long

1,312

37.7625 GBP

1p ordinary

SWAP

Long

1,668

37.7853 GBP

1p ordinary

SWAP

Long

1,925

37.8000 GBP

1p ordinary

SWAP

Long

3,000

37.2238 GBP

1p ordinary

SWAP

Long

4,364

37.5851 GBP

1p ordinary

SWAP

Long

5,850

37.7967 GBP

1p ordinary

SWAP

Long

6,883

37.3560 GBP

1p ordinary

SWAP

Long

8,490

37.3976 GBP

1p ordinary

SWAP

Long

12,689

37.7305 GBP

1p ordinary

SWAP

Short

1

37.6037 GBP

1p ordinary

SWAP

Short

116

37.6200 GBP

1p ordinary

SWAP

Short

133

37.6438 GBP

1p ordinary

SWAP

Short

214

37.7600 GBP

1p ordinary

SWAP

Short

257

37.8200 GBP

1p ordinary

SWAP

Short

888

37.6005 GBP

1p ordinary

SWAP

Short

4,302

37.7697 GBP

1p ordinary

SWAP

Short

4,606

37.7893 GBP

1p ordinary

SWAP

Short

5,438

37.7233 GBP

1p ordinary

SWAP

Short

10,000

37.6030 GBP

1p ordinary

SWAP

Short

10,943

37.7884 GBP

1p ordinary

SWAP

Short

11,034

37.8189 GBP

1p ordinary

SWAP

Short

14,991

37.7209 GBP

1p ordinary

SWAP

Short

15,308

37.8016 GBP

1p ordinary

CFD

Short

17,317

37.6000 GBP

1p ordinary

SWAP

Short

26,221

37.7788 GBP

1p ordinary

SWAP

Short

107,865

37.8000 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

Option money paid/ received per unit

(ii)

Exercising

Class of relevant security

Product description

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of Dealings

Details

Price per unit (if applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights of future acquisition or disposal of any relevant securities to which any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

02 Nov 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

ssw

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETDZMGMRZDGFZG
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.